Lifetime management of TAVI patients: How ACURATE neo2™ optimizes outcomes

Published: 07 June 2021

  • Views:

    Views Icon 41
  • Likes:

    Heart Icon 0

Overview

Full programme

  • Views:

    Views Icon 41
  • Likes:

    Heart Icon 0

Overview

TAVI has evolved over the last few years from a high-risk procedure to a standard of care for patients suffering from aortic valve stenosis. This rapid evolution has led to expanded patient indications and new challenges to safely and efficiently treat more patients who are younger over time.

 

In this webinar, the faculty will discuss latest clinical evidence for the novel ACURATE neo2™ Aortic Valve System designed with a number of new features and to understand how improvements in design may help optimize patient outcomes.

 

The live case from Leipzig, will address the topic of coronary access after TAVI, challenges and solutions to achieve a successful implant that will preserve coronary access for future interventions. Prof Mohamed Abdel-Wahab with Dr Johannes Wilde will provide insights on commissural alignment with the ACURATE Valve Platform. 

 

The discussion will be facilitated by Prof Raj Makkar and Prof Ole De Backer.

This webinar is supported by

Learning Objectives

  • Latest real-world clinical data for ACURATE neo2
  • Coronary access in TAVI and impact of valve design on outcomes
  • Strategies and techniques to achieve commissural alignment

Target Audience

  • Interventional Cardiologists
  • Heart Surgeons
  • Imaging Specialists
  • Nurses

Series overview

Part 1

Welcome and Introduction

1 session

Part 2

Presentation

1 session

  • Latest ACURATE neo2 data releases

    Watch now

Part 3

Live Case from Leipzig Heart Center

1 session

  • Commissural alignment with ACURATE neo2

    Watch now

Faculty biographies